<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kim Y</submitter><funding>National Research Foundation of Korea</funding><pagination>E1694</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7356912</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(6)</volume><pubmed_abstract>This study aimed to understand the clinicopathological significance of runt-related transcription factor 1 (RUNX1) in non-small cell lung cancer (NSCLC). The methylation and mRNA levels of RUNX1 in NSCLC were determined using the Infinium HumanMethylation450 BeadChip and the HumanHT-12 expression BeadChip. RUNX1 protein levels were analyzed using immunohistochemistry of formalin-fixed paraffin-embedded tissues from 409 NSCLC patients. Three CpGs (cg04228935, cg11498607, and cg05000748) in the CpG island of RUNX1 showed significantly different methylation levels (Bonferroni corrected p &lt; 0.05) between tumor and matched normal tissues obtained from 42 NSCLC patients. Methylation levels of the CpGs in the tumor tissues were inversely related to mRNA levels of RUNX1. A logistic regression mode</pubmed_abstract><journal>Journal of clinical medicine</journal><pubmed_title>Clinicopathological Significance of RUNX1 in Non-Small Cell Lung Cancer.</pubmed_title><pmcid>PMC7356912</pmcid><funding_grant_id>2019R1F1A1057654</funding_grant_id><pubmed_authors>Kim DH</pubmed_authors><pubmed_authors>Kim D</pubmed_authors><pubmed_authors>Um S</pubmed_authors><pubmed_authors>Lee BB</pubmed_authors><pubmed_authors>Kim Y</pubmed_authors><pubmed_authors>Cho EY</pubmed_authors><pubmed_authors>Han J</pubmed_authors><pubmed_authors>Shim YM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinicopathological Significance of RUNX1 in Non-Small Cell Lung Cancer.</name><description>This study aimed to understand the clinicopathological significance of runt-related transcription factor 1 (RUNX1) in non-small cell lung cancer (NSCLC). The methylation and mRNA levels of RUNX1 in NSCLC were determined using the Infinium HumanMethylation450 BeadChip and the HumanHT-12 expression BeadChip. RUNX1 protein levels were analyzed using immunohistochemistry of formalin-fixed paraffin-embedded tissues from 409 NSCLC patients. Three CpGs (cg04228935, cg11498607, and cg05000748) in the CpG island of RUNX1 showed significantly different methylation levels (Bonferroni corrected p &lt; 0.05) between tumor and matched normal tissues obtained from 42 NSCLC patients. Methylation levels of the CpGs in the tumor tissues were inversely related to mRNA levels of RUNX1. A logistic regression mode</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jun</publication><modification>2025-04-26T08:15:30.594Z</modification><creation>2025-04-06T12:37:05.165Z</creation></dates><accession>S-EPMC7356912</accession><cross_references><pubmed>32498288</pubmed><doi>10.3390/jcm9061694</doi></cross_references></HashMap>